- Abridge and Kaiser Permanente debut Care Signals
- Built to Serve: The Day That Reminds Us Why We Chose Dentistry
- Journalists Catch You Up on Fauci Hearing, Peptides, and Kids’ Caffeine Consumption
- CMS finalizes 2.3% hospital pay bump, mandatory joint replacement model: 9 things to know
- How ambulatory shifts are reshaping perioperative strategy
- Cyclosporiasis cases top 18,000: 3 updates
- How Allegheny Health Network Strengthened its Foundation for IV Compounding Safety with Automation and Standardization¹
- Health plan customer service reps have AI in their ear
- Centene’s buyouts could have a $315M+ price tag for the rest of the year
- Medicare pay cut sparks specialty battle over skin cancer care
- Cardiovascular Institute of New England provides notice of data incident
- CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date
- Why autonomy — not just capital — is winning over cardiologists
- The $36 vs. $95 problem: How RVU negotiations are skewing physician pay
- Mississippi hospital board member, former CEO remembered as advocate for rural communities
- Pennsylvania SUD treatment locator reaches 146K users
- Top 10 dental, DSO stories in July
- Ohio youth treatment facility faces scrutiny over reported abuse: 8 notes
- What dental leaders told us in July
- Urban hospital closures and net change, by state
- ADSO sues Colorado Dental Board over practice ownership rule
- New patient acquisition is the top growth driver for dental practices: Report
- 20 new behavioral health projects to know
- Nurses, patients protest North Star Health Alliance ASC closure
- No Surprises Act under attack by payers: 8 things to know
- Dental staffing wages up 23% since 2021: ADA
- AtlantiCare appoints anesthesiology, gastroenterology physician leaders
- Consumer dental spending up 24% over 10 years: 5 stats to know
- Baylor Scott & White joint venture expands outpatient behavioral health services
- 5 DSOs making headlines
- VA to explore GLP-1 treatment for alcohol use disorder: 4 notes
- A $5B wave of M&A hits the ASC industry
- FTC Sues Hims & Hers Over Health Privacy And Billing Practices
- 145 physician medical groups led all healthcare M&A sectors in Q1
- 10 new ASCs in July
- Healthcare exec, telemedicine company owner sentenced for $35M DME fraud scheme
- Amylyx demystifies post-bariatric hypoglycemia with patient education website
- What Dad Eats Before Conception May Influence Baby's Health
- Family History Plays Role In Genetic Risk For Breast Cancer, Researchers Find
- A look at employers' attitudes toward ICHRAs
- Revised 340B Rebate Model Pilot Program moves forward, despite provider pushback
- Function Health lands $450M in growth financing to scale tech-enabled preventive health
- Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
- AbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market
- Op-ed: Hospitals on the edge, a time for CMS to do no harm
- Daily Routine Key To Good Health, Study Says
- Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook
- Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis
- Psilocybin Therapy Helps Ease Veterans' Severe PTSD, Pilot Study Finds
- Newsom Reverses On Long-Sought Paid Leave Benefit For California Teachers
- Nicotine Levels Are Rising Among Teens Who Vape, New Study Warns
- The Newest Federally Recognized Tribe Wants Better Healthcare. It May Be On Its Own.
- They Worked To Protect Public Health. Now They Want the Public’s Votes.
- 27 new behavioral health study findings to know
- 21 state behavioral health policy updates
- What will fuel the next wave of DSO growth
- Dentists’ biggest staffing headaches
- Shionogi makes the call on COVID pill Xocova TV spot
- Psilocybin-assisted therapy reduced PTSD symptoms: 3 notes
- Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod
- Psychedelics, peptides and GLP-1s
- How 'physician-led' care team models tackle primary care's workforce problem
- How 7 systems divert behavioral health patients from the ED
- WellSpan Health, Hippocratic AI ink ‘multi-year’ partnership with plans to co-develop clinical AI agents
- Kaiser faces complaint over automated behavioral health triage system
- Free research hub Nila aims to demystify menopause, other hormone conditions
- Scientists Defend Fauci's Pandemic Work As Senate Hearing Turns Bitter
- Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
- Study Questions Effectiveness of Antihistamines in Easing Eczema
- Vaping Is Likely Reshaping The Future Of Cancer In The US, Study Argues
- Weekly Rundown: Counsel Health rolls out white label AI care platform; Community Health Network launches MyChart AI assistant
- New CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat
- Alnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026
- Waystar boosts 2026 outlook as AI-powered RCM solutions gain traction with providers
- YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
- Booming Dupixent sales fuel Regeneron's biggest quarter since pandemic
- Sugar Consumption Early In Life Linked To Increased Dementia Risk, World War II-Era Data Show
- Work Stress Harming Middle-Age Sleep, Study Says
- RFK Jr.'s Gardasil litigation ties subject to fresh lawmaker scrutiny after Merck settlement
- Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat
- Hospice's Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Cell Phone Ownership Linked To Lower Reading Skills In Elementary Students
- Listen to the Latest ‘KFF Health News Minute’
- Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
- Medicaid Insurers’ Contracts on the Line in Tight Governor’s Race
- Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shift
- Cigna CEO: Express Scripts seeing 'significant early interest' from clients for new rebate-free PBM model
- Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
- Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
- FTC sues Hims & Hers over data privacy, billing practices
- CMS' proposed 340B reimbursement cut—who wins, and who loses?
- Virtual care helps patients improve their gambling disorder symptoms, Birches Health finds
- Case Western Reserve University launches next-generation healthcare leadership program
- Lilly, Resilience commit $750M to boost US diabetes, obesity med production
- CMS ending Medicare Part D subsidy program
- Red Cross Declares Rare National Blood Supply Crisis Amid Summer Shortfall
- Not Just Pregnancy Fatigue: Could It Be Sleep Apnea?
- More Women Drinking During Pregnancy
- Wellstar Health System lays off 761 corporate, administrative staff
- Biogen flips '26 guidance from expected decline to sales increase
- Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge
- Talking To Your Baby? Eye Contact Is Key To Language Development, Experiment Shows
- Boosted by CMS settlement, Incyte expects Opzelura to cross $1B in 2026
- Leapfrog launches expanded ASC public reporting program
- Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead
- DoorDash, GrubHub Delivering Junk Food To 1 In 4 Teens During School Hours
- Uninsured but Undaunted, a Surgical Patient Searched the Globe for a Deal
- Trump Has Quietly Throttled an Agency Devoted to the Safety of American Healthcare
- Hospice’s Bad Reputation Amid Fraud Crisis Will Hurt Patients, Industry Experts Warn
- Humana plans more market exits for 2027, CFO says
- PMCPA sanctions melatonin drugmaker over misleading information
- CG Life embraces next-gen era in merger with AI-native agency The Considered+AI
- How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval
- Fifth Death Reported In NYC Legionnaires' Disease Outbreak
- Many Young Adults Aren't Ready To Manage Their Own Healthcare, Poll Finds
- Can A Daily Multivitamin Help You Stay Active As You Age?
- Stellarus launches AI-powered health plan customer service representative copilot
- Prebiotic Soda Health Claims Questioned In New Nutrition Study
- Family-Based Childhood Obesity Program Helps Kids Cut Weight, Become Healthier
- To Afford Aging In Place, Older Adults Turn To 'Golden Girls' Housing
- Breakfast Can Help Teens Make Better Food Choices Throughout Their Day, Study Says
- Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California
- FDA Panel Backs Two Peptides For Compounding, Rejects One
- How Accurate Are Photo-Based Calorie Apps? 4 Are Put To The Test
- Popular School Cafeteria Meals Need An Update To Meet Healthy Food Standards, Researchers Say
- Ovarian Syndrome Quadruples Heart Disease Risk In Women, Major Study Concludes
- Weed-Killing Chemical, Glyphosate, Linked To Premature Births In Humans, Study Says
- 'The Child Is Terrified': Doctors On Front Lines Of Measles Comeback Speak Out
- 'Yo-yo' Weight Loss Linked To Decline In Muscle Mass
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Senate HELP committee advances nominees for CDC director, HHS preparedness head
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
Michigan healthcare freedom community forum
The Council of Economic Advisers (CEA) is an agency within the Executive Office of the President which advises the President on economic policy. The CEA provides much of the empirical economic research for the President and prepares the annual Economic Report of the President. The current Acting CEA Chairperson is Pierre Yared, a professor of International Business at Columbia Business School. The other two current members are Aaron Hedlund and Kim Ruhl.
The CEA released their 11 page report Effects of Banning Hospitals Anti-Steering, Anti-Tiering, and All-or-Nothing Contracts on June 18th. They find these three anticompetitive practices add about 5% to your healthcare bills. Here is the Executive Summary and a link to the full report along with its substantial data set in pdf/zipped format:
https://www.whitehouse.gov/research/2026/06/effects-of-banning-anti-competitive-hospital-contracts/
Executive Summary
Anti-steering, anti-tiering, and all-or-nothing bundled contracting are mechanisms by which dominant hospital systems insulate themselves from price competition: anti-steering prohibits insurers from directing patients toward lower-cost providers; anti-tiering is one form of anti-steering that bars insurers from placing the dominant system in a less favorable benefit tier; and all-or-nothing contracting requires insurers to accept every hospital and affiliated physician in the system or none at all. The DOJ’s February 2026 complaint against OhioHealth and March 2026 complaint against New York-Presbyterian allege that anti-steering restrictions are anticompetitive. Both cases are pending.
This memo develops estimates of the hospital price and health insurance premium reductions that would follow a nationwide ban on all three mechanisms collectively. We estimate that a ban would reduce hospital and affiliated-physician prices by 18 percent (with a plausible range of 11 to 26 percent), averaging ~$4,100 per inpatient admission, in directly affected markets through three channels: restored insurer bargaining leverage, patient sorting to lower-cost providers, and over time, additional price concessions as removing the clauses allows competing systems to become more credible alternatives to insurers. After scaling by the hospital and affiliated-physician share of total employer-sponsored insurance (ESI) spending (approximately 57 percent) and applying a 70 percent pass-through rate, ESI premiums in directly affected markets would fall by an estimated 6.5 percent (ranging from 4 to 9 percent).
In directly affected markets, that premium reduction corresponds to savings of ~$1800 ($1,100 to $2,500) per family annually and ~$600 ($380 to $860) per individual (2025 dollars). Because the economic incidence of ESI premiums falls on workers, these savings flow to employees through some combination of lower out-of-pocket premium costs and higher take-home wages. Reduced hospital prices also raise payroll and employment at non-health-care employers and increase federal income tax receipts, with gains concentrated among lower- and middle-income workers. We estimate that 24 percent of Americans covered by ESI are in markets where these clauses are binding and consequential. Scaling our estimates to account for that indicates that nationwide ESI premium savings of 1.6 percent, amounting to ~$45 billion ($29 to $63 billion) per year.
The expected effects vary by market structure. In markets with a dominant system and competitive insurers, we expect premium reductions of 4 to 6 percent. Where both the hospital system and insurer have market power, the estimated reduction is 2 to 3 percent. In more competitive markets with lower clause prevalence, 1 to 2 percent.
For rural communities, multi-market systems may use anti-steering and all-or-nothing contracts to extend urban market power to rural hospitals, elevating prices in those communities. A ban could reduce premiums for rural workers and employers, improve the negotiating position of independent rural hospitals, and impose minimal pressure on system-owned rural hospitals.
A report from the Epoch Times:
Banning Hospitals’ Certain Contracts Could Save Americans $45 Billion, Report Finds
The Council of Economic Advisers estimated potential savings from a proposed nationwide ban on anti-competitive clauses.
By Travis Gillmore - June 20, 2026WASHINGTON—A ban on certain contracts between hospital systems and health insurers could save Americans around $45 billion, according to a report from White House analysts released on June 18.
“The Council of Economic Advisers’ findings reinforce that the Trump administration is delivering meaningful cost reductions for American patients,” White House spokeswoman Allison Schuster told The Epoch Times by email June 19, noting the president’s surgical approach to policy development that prioritizes fiscal discipline.
“By harnessing the use of free-market competition, President Trump has found a real solution to lowering costs instead of blindly throwing more taxpayer money at the problem.”
Administration officials are exploring how best to manage hospital systems and insurers without relying on price controls or heavy-handed regulations.
At issue are three clauses, known as “anti-steering, anti-tiering, and all-or-nothing” contracts, which critics say shield healthcare providers from competition, thus increasing prices for consumers.
Anti-steering clauses block insurers from incentivizing or guiding clients toward cheaper options or providers, even when their data indicate clear savings potential.
Anti-tiering is used to stop insurers from categorizing hospital systems in less desirable benefit tiers that would reduce profit margins by forcing the providers to cover higher patient costs.
Bundled, also known as all-or-nothing, contracts require insurers to include all hospitals and physicians in a system, eliminating the option to negotiate independently.
Combined, the provisions result in more expensive healthcare, with higher rates, less efficiency, and limited insurance plan innovation due to reduced competition.
In markets where the clauses in question are widespread, a ban would lead to an 18 percent decline in hospital and physician prices, amounting to approximately $4,100 per inpatient admission, according to the report.
Premium prices would decline by about 7 percent, saving the average family about $1,800 annually, the report found, with aggregate reductions totaling about $45 billion and up to $63 billion.
Workers would benefit from higher take-home pay and lower out-of-pocket costs thanks to the reduced insurance costs. Small businesses and employers would also get relief with lower costs.
Analysts arrived at the numbers by calculating several variables, including the increased leverage insurers would gain while bargaining, with an expectation that prices would drop by about 8 percent as a result.
Allowing steering and tiering will improve patient management and shift care toward lower-cost providers, with transparencies helping reduce prices by about 4 percent, according to the report.
Free-market dynamics are expected to drive dynamic competition, with efficient, low-cost competitors helping further drive down costs by about 3 percent.
Proposed policies prioritize healthcare in rural areas, with bans aimed at lowering premiums while boosting independent rural hospitals.
Crackdowns are underway in the form of federal legal proceedings, with eyes on a national framework to codify the proposals.
“Thanks to the Trump administration’s crackdown on anti-steering, anti-tiering, and all-or-nothing contracts by hospitals, everyday Americans are directly benefitting from lower premium contributions and higher take-home wages,” Schuster said.
Congressional lawmakers are considering a similar course of action with the Healthy Competition for Better Care Act introduced by Rep. Jodey Arrington (R-Texas), which would outlaw the anti-competition clauses.
Some states, including Connecticut, Massachusetts, and Texas, prohibit certain clauses, though coverage and enforcement vary.
The report referenced two recent civil antitrust actions brought by the Department of Justice, one against OhioHealth filed in February and settled June 18, with no admission of wrongdoing and the hospital forbidden from using anticompetitive clauses.
“Providing affordable healthcare to Americans is uncontroversial and this Department of Justice will not tolerate corporate prioritization of revenue in contravention of our antitrust laws,” Associate Attorney General Stanley Woodward said in a statement.
A case against New York-Presbyterian Hospital, filed in March, is pending. Justice Department filings allege the hospital is insulated from price competition by contractual clauses, thus raising healthcare costs for New Yorkers.
A settlement with Sutter Health of Northern California from 2022 offers a successful precedent, according to the report, with the system agreeing to pay $575 million in fines and stop using the contractual clauses and succeeding in the aftermath of the agreement, later receiving recognition for its rural facilities.
Trump has repeatedly placed healthcare at the front of his second-term agenda, seeking to address the root causes of high medical costs, including with the release of TrumpRX.gov for prescription medicine at reduced prices.
He’s taken his message on the road around the country in recent weeks, highlighting his actions and plans to further address Americans’ healthcare cost burdens.
More on anti-competitive hospital practices from Alex Berenson:
https://alexberenson.substack.com/p/anti-competitive-hospital-practices
Anti-competitive hospital practices cost American families up to $2,500 a year
Don't take it from me. The number is a (conservative) federal estimate. Much of the extra cash goes to executives like Steven Corwin, who made $26 million in 2024 running a "nonprofit" hospital chain.
By Alex Berenson - June 23, 2026Hospital chains use their market power over private insurers and patients to raise costs by up to $2,500 per American family per year, a new federal report has found.
The report adds to the evidence hospital price increases are helping drive the medical cost crisis, with hospital executives among the biggest beneficiaries.
It highlights a civil suit the Department of Justice filed in March against New York-Presbyterian, a “nonprofit” hospital chain that paid 20 executives $1.5 million or more in 2024, including over $26 million to Dr. Steven Corwin, its chief executive.
Hospital prices have risen almost fourfold since 2000, far more than any other major economic sector. The increase in prices comes after decades of consolidation. Nearly half of medical centers have become part of bigger chains since 2000, largely erasing competition in many cities and metro areas.
The White House Council of Economic Advisers released the report last week, but almost no one aside from healthcare trade reporters has noticed or written about it.
Health insurance company executives are so despised they risk being gunned down. But hospitals continue mostly to escape blame for their role in American healthcare’s exorbitant costs. The report suggests that in many cities and states, hospitals are far more important to high prices — and increasingly dominant over private insurers.
After mergers, hospital chains quickly raise prices, research has shown.
The process is largely invisible to patients, at least at first, because insurance companies pay for most hospitalizations.
As the report explains, insurers can try to push back on price increases by giving patients incentives to use cheaper smaller chains or independent hospitals. But once a chain owns a big enough share of the hospitals in a region, competing hospitals are simply not “credible alternatives to insurers.”
While a few medical centers, like the Mayo Clinic in Minnesota, have national or global reputations, hospitals are mostly a local business. Few sick people want to travel far for surgeries. Dominant local chains have further increased their power by buying physician practices as a way to direct patients both to their main hospitals and outpatient clinics.
And once a chain gets sufficient market power, it can then force insurers not just to cover its facilities but to drop any efforts to move patients away from them.
Chains typically use several different contractual tactics, with names like “anti-steering” or “anti-tiering,” the report explains. But all the terms work the same way, ensuring insurance companies cannot give patients any incentive to save money by using lower-cost hospitals.
The report suggested banning hospitals from those anti-competitive practices could cut the prices health insurers paid by $29 billion to $63 billion nationally. That figure equates to $1,100 to $2,500 per family in regions where hospital mergers have cut competition the most. Insurers would likely pass most savings along, the report suggested.
Chains built around prestigious academic medical centers — like New York-Presbyterian, which owns Columbia University’s flagship hospital — have been particularly aggressive about using their branding power to push prices aggressively, according to the March lawsuit the federal government filed against New York-Presbyterian.
“Because of NYP’s size, brand, and reputation, and the many hospitals and other providers it controls, a payor selling health insurance plans to individuals and employers in Manhattan… must have NYP as a participant in at least some of its provider networks to have successful health insurance products,” the suit alleges.
In 2024, New York-Presbyterian reported revenues of $10.7 billion, up from $10.3 billion the year before, and “revenue less expenses” of $547 milion, up from $499 million. (A regular $11 billion business would refer to “revenue less expenses” as “profit,” but New York-Presbyterian is a nonprofit, see?)
And so it could well afford to pay Dr. Corwin $23.3 million in salary, with another $3 million in “other compensation.”
Yet while the report suggests how much money banning these contracting practices might save, the Trump Administration has not proposed changing regulations or laws to do so.
American medicine may be sick, but consolidation has made hospitals — and their executives — healthier, richer, and more powerful than ever.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























